Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background The purpose of this study was to evaluate the clinical results following intra-articular knee injection of Stromal Vascular Fraction (SVF cell therapy). Methods This study involved 13 consecutive patients who had received SVF cell therapy at our clinic before November 2015 and completed the 6-month post-treatment follow-up period. For each treatment, approximately 200 mL or more of subcutaneous adipose tissue was harvested using tumescent liposuction technique and manual aspiration of tissue from the lower abdomen using a suction cannula under local anesthesia in the operating room. The adipose tissue harvested was processed using the Celution Centrifuge IV in the cell processing room of our clinic. These cells were injected into the articular cavity of both knees directly. Outcome was assessed on the basis of patient questionnaires using VAS for pain, the Japanese Knee Osteoarthritis Measure (JKOM), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Results The 13 patients (26 knee joints), consisting of 2 men and 11 women, had a mean age of 74.5 ± 5.4 years. Eleven patients (9 women, 2 men) presented Grade IV knee OA according to the KL classification. The remaining two patients, both women, had Grade III. Pre-operative scores of JKOM, WOMAC, VAS, and BS-POP (for patients) were 55.9 ± 21.0, 49.6 ± 20.4, 72.7 ± 18.2, and 18.5 ± 2.0. No serious adverse events were reported. One month after injection of SVF, all the scores of JKOM, WOMAC, and VAS were significantly improved over baseline ( P < 0.01). Ultimately, the scores were improved by an average of 35% over baseline for JKOM, 32% improvement in WOMAC, and 40% for pain (VAS). Conclusions Our approach is unique in that it occurred within the context of the recently enacted Japanese Regenerative Medicine Safety Act which is the first in the world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis
Koh, Y.-G., & Choi, Y.-J. (2012) · The Knee · doi:10.1016/j.knee.2012.04.001 · Cited by 392
Cited by
Cell Therapy: Types, Regulation, and Clinical Benefits
El-Kadiry, A. E.-H., Rafei, M., & Shammaa, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.756029 · Cited by 256
Garza, J. R., Campbell, R. E., Tjoumakaris, F. P., Freedman, K. B., Miller, L. S., Santa Maria, D., & Tucker, B. S. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546519899923 · Cited by 200
Shanmugasundaram, S., Vaish, A., Chavada, V., Murrell, W. D., & Vaishya, R. (2021) · International Orthopaedics · doi:10.1007/s00264-020-04926-x · Cited by 39
“5%) used local anaesthesia with tumescent Klein’s solution for adipose tissue harvest, three used general anaesthesia [16, 17, 22], while the details are not known in two [14, 20].”
BackgroundMethodZampogna, B., Parisi, F. R., Ferrini, A., Zampoli, A., Papalia, G. F., Shanmugasundaram, S., & Papalia, R. (2024) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2024.102804 · Cited by 10
“Yokota et al. 39 analyzed 13 patients (26 knees), all received a bilateral injection and the mean cellularity was 3 × 10 7 with a mean age of 74.5 years.”
Influential
Metadata
- Authors
- Yokota, N., Yamakawa, M., Shirata, T., Kimura, T., & Kaneshima, H.
- Venue
- Regenerative Therapy
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 6
- Pages
- 108-112
- ISSN
- 2352-3204 (ISSN-L)
- OpenAlex
- W2614933788
- Cited by
- 90
- References
- 1
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.